HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Rossano Cesari Selected Research
Rossano Cesari Research Topics
Disease
13
Neoplasms (Cancer)
04/2024 - 04/2002
3
Carcinoma (Carcinomatosis)
04/2024 - 04/2004
3
Breast Neoplasms (Breast Cancer)
01/2023 - 03/2003
3
Triple Negative Breast Neoplasms
01/2023 - 10/2013
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 01/2023
2
Pancreatic Neoplasms (Pancreatic Cancer)
11/2004 - 09/2004
2
Carcinogenesis
09/2004 - 04/2002
1
Non-Muscle Invasive Bladder Neoplasms
12/2023
1
Prostatic Neoplasms (Prostate Cancer)
01/2023
1
Ovarian Neoplasms (Ovarian Cancer)
01/2023
1
Fibroma (Fibromatosis)
03/2018
1
Aggressive Fibromatosis (Desmoid)
03/2018
1
Fatigue
01/2018
1
Ataxia Telangiectasia (Louis Bar Syndrome)
11/2008
1
beta-Thalassemia (Cooley's Anemia)
07/2008
1
Anemia
07/2008
1
alpha-Thalassemia
07/2008
1
Urinary Bladder Neoplasms (Bladder Cancer)
11/2004
1
Infections
11/2004
1
Necrosis
04/2002
1
T-Cell Leukemia (Leukemia, T Cell)
04/2002
1
Leukemia
04/2002
Drug/Important Bio-Agent (IBA)
3
Amyloid Precursor Protein Secretases (beta-Secretase)
IBA
03/2018 - 01/2015
3
nirogacestat
IBA
03/2018 - 01/2015
3
Proteins (Proteins, Gene)
FDA Link
11/2008 - 09/2004
3
Histidine (L-Histidine)
FDA Link
11/2004 - 02/2003
2
avelumab
IBA
04/2024 - 01/2023
2
Sunitinib (Sutent)
FDA Link
03/2014 - 10/2013
2
Complementary DNA (cDNA)
IBA
11/2004 - 04/2004
1
Cisplatin (Platino)
FDA Link
Generic
04/2024
1
Pemetrexed (MTA)
FDA Link
04/2024
1
Carboplatin (JM8)
FDA Link
Generic
04/2024
1
Gemcitabine
FDA Link
04/2024
1
Ligands
IBA
12/2023
1
Biomarkers (Surrogate Marker)
IBA
01/2023
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
01/2023
1
Antigens
IBA
01/2023
1
Immune Checkpoint Inhibitors
IBA
01/2023
1
Platinum
IBA
01/2023
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2023
1
Hormones (Hormone)
IBA
01/2023
1
Prostate-Specific Antigen (Semenogelase)
IBA
01/2023
1
human ERBB2 protein
IBA
01/2023
1
talazoparib
IBA
01/2023
1
Catenins
IBA
03/2018
1
utomilumab
IBA
01/2018
1
Transaminases (Aminotransferases)
IBA
01/2018
1
Docetaxel (Taxotere)
FDA Link
01/2017
1
glasdegib
IBA
01/2015
1
Trastuzumab (Herceptin)
FDA Link
03/2014
1
Phosphotransferases (Kinase)
IBA
11/2008
1
Hemoglobins (Hemoglobin)
IBA
07/2008
1
beta-Globins (beta Globin)
IBA
07/2008
1
DNA (Deoxyribonucleic Acid)
IBA
08/2007
1
fragile histidine triad protein
IBA
11/2004
1
Nitrosamines
IBA
11/2004
1
Class 3 Receptor-Like Protein Tyrosine Phosphatases
IBA
11/2004
1
1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)
IBA
11/2004
1
Oligodeoxyribonucleotides
IBA
09/2004
1
diadenosine polyphosphate hydrolase
IBA
02/2003
1
Transferases
IBA
02/2003
1
Nucleosides
IBA
02/2003
1
Hydrolases
IBA
02/2003
1
sulforaphane
IBA
04/2002
1
glucoraphanin
IBA
04/2002
1
bcl-2-Associated X Protein (bcl 2 Associated X Protein)
IBA
04/2002
1
Glucosinolates
IBA
04/2002
1
isothiocyanic acid
IBA
04/2002
1
Enzymes
IBA
04/2002
1
Carcinogens
IBA
04/2002
Therapy/Procedure
2
Drug Therapy (Chemotherapy)
04/2024 - 10/2013
2
Therapeutics
07/2008 - 09/2004
1
Transurethral Resection of Bladder
12/2023
1
Immunotherapy
12/2023
1
Castration
01/2023
1
Oral Administration
01/2015
1
Transplantation
07/2008
1
Aftercare (After-Treatment)
11/2004